Serial Number | 97125105 |
Word Mark | AIRNECFLU |
Filing Date | Monday, November 15, 2021 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, April 1, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 4, 2023 |
Goods and Services | Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, hyperactivity, anxiety, bipolar disorder, and other central nervous system disorders; medicines for human purposes namely, for improving basic behavioral functioning, suicidal ideation and behavior, sensorimotor gating, pain threshold, memory and cognitive functioning and loss weight; sedatives; nervines for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS); gases for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS);nasal spray for treating respiratory tract infections caused by viruses or bacteria; oral spray for treating respiratory tract infections caused by viruses or bacteria |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, November 19, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | SyneuRx International (Taiwan) Corp. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New Taipei City 221 TW |
Party Name | SyneuRx International (Taiwan) Corp. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New Taipei City 221 TW |
Event Date | Event Description |
Monday, April 1, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, April 1, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, August 29, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, July 4, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 4, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, June 14, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, June 1, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, May 2, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, May 2, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, May 2, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Saturday, February 11, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Saturday, February 11, 2023 | FINAL REFUSAL E-MAILED |
Saturday, February 11, 2023 | FINAL REFUSAL WRITTEN |
Thursday, December 29, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, December 29, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, December 29, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, August 25, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, August 25, 2022 | NON-FINAL ACTION E-MAILED |
Thursday, August 25, 2022 | NON-FINAL ACTION WRITTEN |
Thursday, August 25, 2022 | ASSIGNED TO EXAMINER |
Friday, November 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 18, 2021 | NEW APPLICATION ENTERED |